Asbjørn Jokstad

Prof. Dr. Asbjørn Jokstad


Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2018 in Clinical Oral Implants Research
Verified
Journal Article
Open access
PDF file
RJRonald E. Jung
Ronald E. Jung
BABilal Al-Nawas
Bilal Al-Nawas
MAMauricio Araujo
Mauricio Araujo
GAGustavo Avila-Ortiz
Gustavo Avila-Ortiz
SBStephen Barter
Stephen Barter
PWPéter Windisch
Péter Windisch
Objectives: The aim of Working Group 1 was to address the influence of different local (implant length, diameter, and design) and systemic (medications) factors on clinical, radiographic, and patient‐reported outcomes in implant dentistry. Focused questions on (a) short posterior dental implants (≤6 mm), (b) narrow diameter implants, (c) implant design (tapered compared to a non‐tapered implant design), and (d) medication‐related dental implant failures were addressed.Materials and methods: Four systematic reviews were prepared in advance of the Consensus Conference and were discussed among the participants of Group 1. Consensus statements, clinical recommendations, and recommendations for future research were based on structured group discussions until consensus was reached among the entire expert Group 1. The statements were then presented and accepted following further discussion and modifications as required by the plenary.Results: Short implants (≤6 mm) revealed a survival rate ranging from 86.7% to 100%, whereas standard implant survival rate ranged from 95% to 100% with a follow‐up from 1 to 5 years. Short implants demonstrated a higher variability and a higher Risk Ratio [RR: 1.24 (95% CI: 0.63, 2.44, p = 0.54)] for failure compared to standard implants.Narrow diameter implants (NDI) have been classified into three categories: Category 1: Implants with a diameter of <2.5 mm (“Mini‐implants”); Category 2: Implants with a diameter of 2.5 mm to <3.3 mm; Category 3: Implants with a diameter of 3.3 mm to 3.5 mm. Mean survival rates were 94.7 ± 5%, 97.3 ± 5% and 97.7 ± 2.3% for category 1, 2 and 3.Tapered versus non‐tapered implants demonstrated only insignificant differences regarding clinical, radiographic, and patient‐reported outcomes. The intake of certain selective serotonin reuptake inhibitors and proton pump inhibitors is associated with a statistically significant increased implant failure rate. The intake of bisphosphonates related to the treatment of osteoporosis was not associated with an increased implant failure rate.Conclusions: It is concluded that short implants (≤6 mm) are a valid option in situations of reduced bone height to avoid possible morbidity associated with augmentation procedures; however, they reveal a higher variability and lower predictability in survival rates. Narrow diameter implants with diameters of 2.5 mm and more demonstrated no difference in implant survival rates compared to standard diameter implants. In contrast, it is concluded that narrow diameter implants with diameters of less than 2.5 mm exhibited lower survival rates compared to standard diameter implants. It is further concluded that there are no differences between tapered versus non‐tapered dental implants.Certain medications such as selective serotonin reuptake inhibitors and proton pump inhibitors showed an association with a higher implant failure rate.

1 December 2003 in International Dental Journal
Verified
Journal Article
Closed access
PDF file
AJAsbjørn Jokstad
Asbjørn Jokstad
UBUrs Braegger
Urs Braegger
JBJohn B. Brunski
John B. Brunski
ACAlan B. Carr
Alan B. Carr
INIgnace Naert
Ignace Naert
AWAnn Wennerberg
Ann Wennerberg

1 June 2001 in International Dental Journal
Verified
Journal Article
Closed access
PDF file
AJAsbjørn Jokstad
Asbjørn Jokstad
SBStephen Bayne
Stephen Bayne
UBUwe Blunck
Uwe Blunck
MTMartin Tyas
Martin Tyas
NWNairn Wilson
Nairn Wilson

1 March 1997 in Journal of Dentistry
Verified
Journal Article
Closed access
JVJ. Valderhaug
J. Valderhaug
AJAsbjørn Jokstad
Asbjørn Jokstad
EAE. Ambjørnsen
E. Ambjørnsen
PNP.W. Norheim
P.W. Norheim

1 January 2016 in Dental Materials
Verified
Journal Article
Open access
AJAsbjørn Jokstad
Asbjørn Jokstad
To critically appraise experimental ex vivo research that has focused on secondary caries, and to offer possible explanations for the seemingly poor correlation to clinical observations. The literature relating to the etiopathogenesis or prevention of secondary caries gained from experimental ex vivo research was reviewed, with particular emphasis on microleakage and artificial caries-like lesions. It is doubtful whether a caries wall lesion can exist independently of an outer enamel caries lesion. Microleakage experiments apparently continue to emerge regardless of multiple reviews questioning the reliability and validity of the method. Several of the approaches used to generate artificial caries-like lesions are very aggressive. Remarkably little discussion has evolved about how these aggressive approaches create microenvironments that do not occur in reality. Corrosion- and biodegradation products may influence the biofilm qualitatively and quantitatively and it is difficult to replicate these variables in any ex vivo environment. Clinical data sampling method, patient demography as well as study methodology influences the incidence and prevalence estimates of secondary caries. Clinical results based on clinical work in settings where cost per unit time is of nominal concern do not provide any indications on how the restorative material will perform when placed by the average dentists in the mouths of their spectrum of patients during a busy workday. The term "wall lesion" including its variants is ill defined, has been, and is still being used indiscriminately. Stakeholders should avoid using this ambiguous label due to its connotation to an entity that does not exist per se.

19 May 2014 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
ESEszter Somogyi‐Ganss
Eszter Somogyi‐Ganss
HHHoward I. Holmes
Howard I. Holmes
AJAsbjørn Jokstad
Asbjørn Jokstad